PHESGO

Brand Description

PHESGO is a fixed-dose subcutaneous treatment combining pertuzumab and trastuzumab for HER2-positive breast cancer, designed for efficient administration and patient care.

Associated Domains

Screenshot of www.phesgo-hcp.com
www.phesgo-hcp.com

IAB Categories:

Health & Fitness

IAB Ad Products:

Health and Medical ServicesPharmaceuticals
IDDomainSeatBidTimestampStatusAd FormatSub FormatSizeQuality ScoreData TransferredComputational Cost